UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): April 30, 2012
C. R. BARD, INC.
(Exact Name of Registrant as Specified in Charter)
| New Jersey | 001-6926 | 22-1454160 | ||
| (State or Other Jurisdiction of Incorporation or Organization) |
(Commission File Number) |
(IRS Employer Identification No.) |
| 730 Central Avenue Murray Hill, New Jersey |
07974 | |||
| (Address of Principal Executive Office) | (Zip Code) | |||
(908) 277-8000
(Registrant’s Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On April 30, 2012, the Board of Directors (the “Board”) of C. R. Bard, Inc. appointed Christopher S. Holland as Senior Vice President and Chief Financial Officer, effective on his date of hire, which is expected to be May 21, 2012 (the “Effective Date”). In this role, Mr. Holland will report directly to Timothy M. Ring, Chairman and Chief Executive Officer. The Company’s appointment of Mr. Holland was announced in a press release, dated April 30, 2012, attached to this Form 8-K as Exhibit 99.1.
Mr. Holland, age 45, has most recently served as Senior Vice President, Finance and Treasurer of ARAMARK Corporation, as Senior Vice President and Treasurer from 2006 through 2010, and as Vice President and Treasurer from 2003 to 2006. Prior to joining ARAMARK, Mr. Holland served as Vice President and medical device sector head at J. P. Morgan and Company, Inc. from 1999 to 2003, and held various positions of increasing responsibility at J. P. Morgan from 1988 to 1999, including in accounting and healthcare corporate finance.
Mr. Holland holds a B.A. in Economics and Political Science from Drew University, and an M.B.A. in Finance from New York University – Leonard N. Stern School of Business.
Mr. Holland will participate on the same basis as all other executive officers in the Company’s 2012 Long Term Incentive Plan, Management Stock Purchase Program, Employees’ Retirement Plan, Supplemental Executive Retirement Plan and Supplemental Insurance/Retirement Plan. These plans are described in more detail under the heading “Executive Officer Compensation” in the Company’s proxy statement on Schedule 14A filed with the Securities and Exchange Commission on March 16, 2012.
| Item 9.01 | Financial Statements and Exhibits |
| (d) | Exhibits | |
| 99.1 | Press Release, dated April 30, 2012 | |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| C. R. BARD, INC. | ||
| (Registrant) | ||
| By: | /s/ Richard C. Rosenzweig | |
| Name: | Richard C. Rosenzweig | |
| Title: | Vice President, Law and Assistant Secretary | |
April 30, 2012
Exhibit Index
| 99.1 | Press Release, dated April 30, 2012 |
Exhibit 99.1
Contacts:
| Investor Relations: | Todd W. Garner | |
| Vice President, Investor Relations | ||
| (908) 277-8065 | ||
| Media Relations: | Scott T. Lowry | |
| Vice President and Treasurer | ||
| (908) 277-8365 | ||
Bard Names Christopher S. Holland
Senior Vice President and Chief Financial Officer
MURRAY HILL, NJ — (April 30, 2012) — C. R. Bard, Inc. (NYSE: BCR) today announced that Christopher S. Holland has been named Senior Vice President and Chief Financial Officer, effective May 21, 2012. In this role, Mr. Holland will report directly to Timothy M. Ring, Chairman and Chief Executive Officer.
Mr. Holland, age 45, has most recently served as Senior Vice President, Finance and Treasurer of ARAMARK Corporation, as Senior Vice President and Treasurer from 2006 through 2010, and as Vice President and Treasurer from 2003 to 2006. Prior to joining ARAMARK, Mr. Holland served as Vice President and medical device sector head at J. P. Morgan and Company, Inc. from 1999 to 2003, and held various positions of increasing responsibility at J.P. Morgan from 1988 to 1999, including in accounting and healthcare corporate finance.
Mr. Holland holds a B.A. in Economics and Political Science from Drew University, and an M.B.A. in Finance from New York University – Leonard N. Stern School of Business.
Mr. Ring commented, “Chris is a seasoned executive with extensive finance, operations and business development experience. I expect Chris to integrate seamlessly into our organization, and look forward to working closely with him as we continue to position Bard for healthy long-term growth.”
Mr. Holland commented, “I am thrilled to be joining Bard. Bard enjoys a strong reputation as a leading medical device company with a successful product leadership strategy. I look forward to working with the talented team at Bard and helping to drive further success for this great company.”
C. R. Bard, Inc. (www.crbard.com), headquartered in Murray Hill, N.J., is a leading multinational developer, manufacturer and marketer of innovative, life-enhancing medical technologies in the fields of vascular, urology, oncology and surgical specialty products.
This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management’s current expectations, the accuracy of which is necessarily subject to risks and uncertainties. These statements are not historical in nature and use words such as “anticipate”, “estimate”, “expect”, “project”, “intend”, “forecast”, “plan”, “believe”, and other words of similar meaning in connection with any discussion of future operating or financial performance. Many factors may cause actual results to differ materially from anticipated results including product developments, sales efforts, income tax matters, the outcomes of contingencies such as legal proceedings, and other economic, business, competitive and regulatory factors. The company undertakes no obligation to update its forward-looking statements. Please refer to the Cautionary Statement Regarding Forward-Looking Information in our March 31, 2012 Form 10-Q for more detailed information about these and other factors that may cause actual results to differ materially from those expressed or implied.